185 related articles for article (PubMed ID: 15628053)
1. [Serum interleukin-6 concentrations in patients with alcoholic liver disease].
Swiatkowska-Stodulska R; Bakowska A
Pol Merkur Lekarski; 2004 Sep; 17(99):255-9. PubMed ID: 15628053
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 in the blood serum of patients with alcoholic liver disease.
Swiatkowska-Stodulska R; Bakowska A; Drobińska-Jurowiecka A
Med Sci Monit; 2006 May; 12(5):CR215-20. PubMed ID: 16641879
[TBL] [Abstract][Full Text] [Related]
3. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 and alcoholic liver disease.
Huang YS; Wu JC; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):395-401. PubMed ID: 10418175
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients.
Khoruts A; Stahnke L; McClain CJ; Logan G; Allen JI
Hepatology; 1991 Feb; 13(2):267-76. PubMed ID: 1995437
[TBL] [Abstract][Full Text] [Related]
6. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis.
Diez Ruiz A; Santos Perez JL; Lopez Martinez G; Gonzalez Calvín J; Gil Extremera B; Gutierrez Gea F
Alcohol Alcohol; 1993 May; 28(3):319-23. PubMed ID: 8352843
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of cytokines in alcoholic liver cirrhosis and pancreatitis.
Szuster-Ciesielska A; Daniluk J; Kandefer-Zerszeń M
Arch Immunol Ther Exp (Warsz); 2000; 48(4):301-7. PubMed ID: 11059648
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease.
Urbaschek R; McCuskey RS; Rudi V; Becker KP; Stickel F; Urbaschek B; Seitz HK
Alcohol Clin Exp Res; 2001 Feb; 25(2):261-8. PubMed ID: 11236841
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of serum hyaluronate concentrations in patients with alcoholic liver disease.
Tsutsumi M; Urashima S; Takase S; Ueshima Y; Tsuchishima M; Shimanaka K; Kawahara H
Alcohol Clin Exp Res; 1997 Dec; 21(9):1716-21. PubMed ID: 9438536
[TBL] [Abstract][Full Text] [Related]
11. [Serum cytokine concentration as prognostic factor in patients with alcoholic liver disease].
Ciećko-Michalska I; Szczepanek M; Cibor D; Owczarek D; Skulina D; Szczepański W; Michalski M
Przegl Lek; 2006; 63(5):249-52. PubMed ID: 17036498
[TBL] [Abstract][Full Text] [Related]
12. The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation.
Wells JT; Said A; Agni R; Tome S; Hughes S; Dureja P; Lucey MR
Liver Transpl; 2007 Dec; 13(12):1728-35. PubMed ID: 18044757
[TBL] [Abstract][Full Text] [Related]
13. The influence of ethanol and liver disease on sex hormones and hepatic oestrogen receptors in women.
Becker U
Dan Med Bull; 1993 Sep; 40(4):447-59. PubMed ID: 8222764
[TBL] [Abstract][Full Text] [Related]
14. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
[TBL] [Abstract][Full Text] [Related]
16. [Sex difference in alcoholic liver disease: with special reference to the severity of alcoholic hepatitis].
Furube M; Sugimoto M; Asakura I; Mizukami H; Akita H; Hatori T; Abei T; Sasaki K
Arukoru Kenkyuto Yakubutsu Ison; 1989 Jun; 24(3):135-43. PubMed ID: 2803107
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.
Migita K; Abiru S; Maeda Y; Daikoku M; Ohata K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Hum Immunol; 2006; 67(1-2):27-32. PubMed ID: 16698422
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin-2 and interleukin-6 in serum as markers of disease progression in systemic sclerosis].
Lis A; Brzezińska-Wcisło L
Pol Merkur Lekarski; 2001 Sep; 11(63):206-9. PubMed ID: 11761811
[TBL] [Abstract][Full Text] [Related]
20. Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis.
Wiest R; Weigert J; Wanninger J; Neumeier M; Bauer S; Schmidhofer S; Farkas S; Scherer MN; Schäffler A; Schölmerich J; Buechler C
Cytokine; 2011 Feb; 53(2):178-83. PubMed ID: 20637651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
